126 related articles for article (PubMed ID: 28537669)
21. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
22. Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.
Pils D; Bachmayr-Heyda A; Auer K; Svoboda M; Auner V; Hager G; Obermayr E; Reiner A; Reinthaller A; Speiser P; Braicu I; Sehouli J; Lambrechts S; Vergote I; Mahner S; Berger A; Cacsire Castillo-Tong D; Zeillinger R
Eur J Cancer; 2014 Jan; 50(1):99-110. PubMed ID: 24176298
[TBL] [Abstract][Full Text] [Related]
23. An MCM4 mutation detected in cancer cells affects MCM4/6/7 complex formation.
Tatsumi R; Ishimi Y
J Biochem; 2017 Mar; 161(3):259-268. PubMed ID: 27794528
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG
Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349
[TBL] [Abstract][Full Text] [Related]
25. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
26. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
Li Y; Sturgis EM; Zhu L; Cao X; Wei Q; Zhang H; Li G
Mol Carcinog; 2017 Apr; 56(4):1335-1343. PubMed ID: 27864908
[TBL] [Abstract][Full Text] [Related]
27. miR-31 promotes proliferation of colon cancer cells by targeting E2F2.
Li T; Luo W; Liu K; Lv X; Xi T
Biotechnol Lett; 2015 Mar; 37(3):523-32. PubMed ID: 25362258
[TBL] [Abstract][Full Text] [Related]
28. Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.
Bollig-Fischer A; Marchetti L; Mitrea C; Wu J; Kruger A; Manca V; Drăghici S
Bioinformatics; 2014 Nov; 30(21):3036-43. PubMed ID: 25028721
[TBL] [Abstract][Full Text] [Related]
29. G364R mutation of MCM4 detected in human skin cancer cells affects DNA helicase activity of MCM4/6/7 complex.
Ishimi Y; Irie D
J Biochem; 2015 Jun; 157(6):561-9. PubMed ID: 25661590
[TBL] [Abstract][Full Text] [Related]
30. HPV-type-specific response of cervical cancer cells to cisplatin after silencing replication licensing factor MCM4.
Das M; Prasad SB; Yadav SS; Modi A; Singh S; Pradhan S; Narayan G
Tumour Biol; 2015 Dec; 36(12):9987-94. PubMed ID: 26188903
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of
Zheng R; Lai G; Li R; Hao Y; Cai L; Jia J
J Gastrointest Oncol; 2021 Feb; 12(1):153-173. PubMed ID: 33708433
[TBL] [Abstract][Full Text] [Related]
32. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
34. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
35. Prognostic values of S100 family members in ovarian cancer patients.
Bai Y; Li LD; Li J; Lu X
BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells.
Zhou J; Xie M; Shi Y; Luo B; Gong G; Li J; Wang J; Zhao W; Zi Y; Wu X; Wen J
Oncol Rep; 2015 Jul; 34(1):111-20. PubMed ID: 25954928
[TBL] [Abstract][Full Text] [Related]
37. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions.
Choy B; LaLonde A; Que J; Wu T; Zhou Z
Hum Pathol; 2016 Nov; 57():126-135. PubMed ID: 27476776
[TBL] [Abstract][Full Text] [Related]
38. E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.
Chen L; Yu JH; Lu ZH; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10545-54. PubMed ID: 26617764
[TBL] [Abstract][Full Text] [Related]
39. Increased metastasis with loss of E2F2 in Myc-driven tumors.
Yuwanita I; Barnes D; Monterey MD; O'Reilly S; Andrechek ER
Oncotarget; 2015 Nov; 6(35):38210-24. PubMed ID: 26474282
[TBL] [Abstract][Full Text] [Related]
40. c-ETS transcription factors play an essential role in the licensing of human MCM4 origin of replication.
Sidhu K; Kumar V
Biochim Biophys Acta; 2015 Nov; 1849(11):1319-28. PubMed ID: 26365772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
